NAV

Human Amniotic Fluid

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Human Amniotic Fluid
DrugBank Accession Number
DB15871
Background

Human amniotic fluid is the liquid surrounding the human embryo and fetus.1 Physically, the fluid provides protection through cushioning. Chemically, the fluid provides protection through its inherent antibacterial properties. The fluid contains carbohydrates, proteins, lipids, electrolytes, urea, immunoglobulins, growth factors, and vitamins.1,2

Type
Biotech
Groups
Investigational
Synonyms
Not Available
External IDs
  • Human Amniotic Fluid

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action

Human amniotic fluid was seen to reduce inflammation in lungs of COVID-19 patients through a decrease in C-reactive protein in a study.2 However, the mechanisms of action of this therapy are unclear. Currently, human amniotic fluid is being investigated against COVID-19.

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
6SQ06FQ2GH
CAS number
Not Available

References

General References
  1. National Center for Biotechnology Information: Embryology, Amniotic Fluid [Link]
  2. University of Utah Health: AMNIOTIC FLUID COULD REDUCE ACUTE SYMPTOMS, LONG-TERM RISKS OF COVID-19 [Link]
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Not Yet RecruitingTreatmentVenous Leg Ulcer (VLU) / Venous Stasis Ulcers (VSU)1
1, 2RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19)1
1, 2RecruitingTreatmentOsteoarthritis of the Knee1
0RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19)1
Not AvailableUnknown StatusTreatmentFatty Atrophy / Rotator Cuff Tears1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on September 21, 2020 17:22 / Updated on September 22, 2020 13:00